A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.

J Interv Card Electrophysiol · 2015 · PMC4346668 · PMID 25638303

Europe PMC DOI

hedged sentence

0.0015

closest p · 0.0× alpha

0.0015

boldest claim

The sentences

highly significantP = 0.0015actually significant

The study, however, was analyzed as originally planned with the primary endpoint achieving a highly significant ( P = 0.0015) outcome.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.